BioSpace News Archive

Brickell Biotech, Inc. announced that its Japanese development partner, Kaken Pharmaceutical Co., Ltd., received approval to manufacture and market sofpironium bromide gel, 5% under the brand name ECCLOCK® in Japan for the treatment of primary axillary hyperhidrosis.

TELA Bio, Inc. announced that additional data from its BRAVO study were presented virtually as posters at the Americas Hernia Society Annual Meeting.

CB2 Insights Inc. (“ CB2 ” or the “ Company ”) (CSE: CBII; OTCQB: CBIIF), one of the largest integrative healthcare systems in the United States, is pleased to announce that it has upsized and closed its previously announced non-brokered private placement financing (the “Placement”) of units of the Company (the “Units”) led by Merida Capital Partners. The Company issued 34,253,641 Units at an issue price of C$0.15 per Unit (the “Issue Price”) for

Freeline Therapeutics Holdings plc announced that Theresa Heggie, Chief Executive Officer, will present at the Chardan Virtual 4th Annual Global Healthcare Conference on October 6 at 4:45pm EDT.

Closed non-brokered and oversubscribed Private Placements for total gross proceeds of $2.6 million, including $353,000 from management and Board members

REGENXBIO Inc., announced it will participate in the following upcoming investor conferences, which will each be held in a virtual meeting format:

Accent Therapeutics, a biopharmaceutical company developing breakthrough treatments for cancer patients, announced today the appointment of Julie Hambleton, M.D., to its board of directors. Dr. Hambleton brings extensive clinical oncology drug development and regulatory expertise gained in leadership roles within both the biotechnology and pharmaceutical industries. “We are delighted to welcome Julie to the Accent

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the appointment of Rita Balice-Gordon to its Board of Directors, effective September 24, 2020.